Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Olivier, Christoph B."" wg kryterium: Autor


Wyświetlanie 1-27 z 27
Tytuł :
Antithrombotische Therapie nach strukturellen kardialen Interventionen: Empfehlung der Arbeitsgruppe Kardiovaskuläre Hämostase und Antithrombotische Therapie (AG19) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK) in Zusammenarbeit mit der Arbeitsgruppe Interventionelle Kardiologie (AG6) – AGIK und der Arbeitsgruppe Klinische Pharmakologie (AG22) der DGK
Autorzy :
Hochholzer, Willibald
Nührenberg, Thomas
Flierl, Ulrike
Olivier, Christoph B.
Landmesser, UlfAff4, Aff12
Möllmann, Helge
Dörr, Marcus
Mehilli, Julinda
Schäfer, Andreas
Dürschmied, Daniel
Sibbing, Dirk
El-Armouche, Ali
Zeymer, Uwe
Neumann, Franz-Josef
Ahrens, Ingo
Geisler, Tobias
Pokaż więcej
Alternatywny tytuł :
Antithrombotic therapy after structural cardiac interventions: Recommendations of the Working Group on Cardiovascular Hemostasis and Antithrombotic Therapy (AG19) of the German Cardiac Society (DGK) in cooperation with the Working Group on Interventional Cardiology (AG6, AGIK) and the Working Group on Clinical Pharmacology (AG22) of the DGK
Źródło :
Der Kardiologe. 15(1):57-70
Czasopismo naukowe
Tytuł :
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting
Autorzy :
Rilinger, Jonathan
Meyer, Melanie
Schnabel, Katharina
Weik, Patrick
Charlet, Anne
Esser, Jennifer S.
Zhou, Qian
Bode, Christoph
Moser, Martin
Diehl, Philipp
Olivier, Christoph B.
Pokaż więcej
Źródło :
Journal of Thrombosis and Thrombolysis: A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science. November 2016 42(4):558-565
Czasopismo naukowe
Tytuł :
Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors
Autorzy :
Olivier, Christoph B.
Weik, Patrick
Meyer, Melanie
Weber, Susanne
Diehl, Philipp
Bode, Christoph
Moser, Martin
Zhou, Qian
Pokaż więcej
Źródło :
Journal of Thrombosis and Thrombolysis: A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science. August 2016 42(2):161-166
Czasopismo naukowe
Tytuł :
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel
Autorzy :
Olivier, Christoph B.
Schnabel, Katharina
Weber, Susanne
Zhou, Qian
Bode, Christoph
Moser, Martin
Diehl, Philipp
Pokaż więcej
Źródło :
Journal of Thrombosis and Thrombolysis: A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science. July 2016 42(1):84-89
Czasopismo naukowe
Tytuł :
A high ratio of ADP–TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone
Autorzy :
Olivier, Christoph B.
Schnabel, Katharina
Brandt, Christoph
Weik, Patrick
Olschewski, Manfred
Zhou, Qian
Bode, Christoph
Diehl, Philipp
Moser, Martin
Pokaż więcej
Źródło :
Clinical Research in Cardiology. December 2014 103(12):968-975
Czasopismo naukowe
Tytuł :
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.
Autorzy :
Yong, Celina M.
Sundaram, Vandana
Abnousi, Freddy
Olivier, Christoph B.
Yang, Jaden
Stone, Gregg W.
Steg, Philippe G.
Michael Gibson, C.
Hamm, Christian W.
Price, Matthew J.
Deliargyris, Efthymios N.
Prats, Jayne
White, Harvey D.
Harrington, Robert A.
Bhatt, Deepak L.
Mahaffey, Kenneth W.
Pokaż więcej
Źródło :
Clinical Cardiology; Sep2019, Vol. 42 Issue 9, p797-805, 9p
Czasopismo naukowe
Tytuł :
Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
Autorzy :
Olivier CB; Department of Medicine, Stanford Center for Clinical Research (C.B.O., K.W.M.), Stanford University School of Medicine, CA.; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany (C.B.O.).
Fan J; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Askari M; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Mahaffey KW; Department of Medicine, Stanford Center for Clinical Research (C.B.O., K.W.M.), Stanford University School of Medicine, CA.
Heidenreich PA; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Perino AC; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Leef GC; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Ho PM; Division of Cardiology, Denver VA Medical Center, CO (P.M.H.).
Harrington RA; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Department of Medicine, Center for Digital Health (R.A.H., M.P.T.), Stanford University School of Medicine, CA.
Turakhia MP; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Department of Medicine, Center for Digital Health (R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Pokaż więcej
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2019 Aug; Vol. 12 (8), pp. e007604. Date of Electronic Publication: 2019 Aug 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Coronary Artery Disease/*therapy
Fibrinolytic Agents/*administration & dosage
Healthcare Disparities/*trends
Platelet Aggregation Inhibitors/*administration & dosage
Practice Patterns, Physicians'/*trends
Purinergic P2Y Receptor Antagonists/*administration & dosage
Stroke/*prevention & control
Aged ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Drug Utilization/trends ; Female ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Time Factors ; Treatment Outcome ; United States/epidemiology ; United States Department of Veterans Affairs ; Veterans Health
Czasopismo naukowe
Tytuł :
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.
Autorzy :
Olivier CB; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, CA (C.B.O., K.W.M.).; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany (C.B.O.).
Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Leonardi S; University of Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy (S.L.).
Stone GW; Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY (G.W.S.).
Gibson CM; Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, MA (C.M.G.).
Steg PG; FACT (French Alliance for Cardiovascular Clinical Trials), DHU FIRE, INSERM Unité 1148, Université Paris-Diderot, and Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France, and NHLI, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.).
Hamm CW; Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany (C.W.H.).
Wilson MD; Duke University Medical Center, Durham, NC (M.D.W., S.M., R.D.L.).
Mangum S; Duke University Medical Center, Durham, NC (M.D.W., S.M., R.D.L.).
Price MJ; Scripps Clinic and Scripps Translational Science Institute, La Jolla, CA (M.J.P.).
Prats J; Elysis Llc, Carlisle, MA (J.P.).
White HD; Green Lane Cardiovascular Service, Auckland, New Zealand (H.D.W.).
Lopes RD; Duke University Medical Center, Durham, NC (M.D.W., S.M., R.D.L.).
Harrington RA; Department of Medicine, Stanford University School of Medicine, Stanford, CA (R.A.H.).
Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, CA (C.B.O., K.W.M.).
Pokaż więcej
Corporate Authors :
CHAMPION PHOENIX Investigators *
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2019 Jul; Vol. 12 (7), pp. e007342. Date of Electronic Publication: 2019 Jul 12.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Research Design*
Adenosine Monophosphate/*analogs & derivatives
Coronary Artery Disease/*therapy
Coronary Thrombosis/*prevention & control
Myocardial Infarction/*prevention & control
Percutaneous Coronary Intervention/*adverse effects
Platelet Aggregation Inhibitors/*therapeutic use
Adenosine Monophosphate/adverse effects ; Adenosine Monophosphate/therapeutic use ; Coronary Artery Disease/complications ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Coronary Thrombosis/diagnosis ; Coronary Thrombosis/etiology ; Coronary Thrombosis/mortality ; Humans ; Myocardial Infarction/diagnosis ; Myocardial Infarction/etiology ; Myocardial Infarction/mortality ; Percutaneous Coronary Intervention/mortality ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-27 z 27

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies